Mabuchi Haruna, Kajita Naoki, Kusakawa Go, Morita Kumiko, Yoshida Koichi
Division of Allergy, Tokyo Metropolitan Children's Medical Center, Fuchu, JPN.
Department of Pediatrics, National Defense Medical College Hospital, Tokorozawa, JPN.
Cureus. 2025 Feb 19;17(2):e79317. doi: 10.7759/cureus.79317. eCollection 2025 Feb.
Trimethoprim-sulfamethoxazole (TMP-SMX) is a non-β-lactam antibiotic commonly used in pediatrics to treat infections and as a prophylactic medication. Hypersensitivity to TMP-SMX is generally non-immediate, and immediate allergic reactions, including anaphylaxis, are rare. This case report details a six-year-old girl who experienced anaphylaxis to TMP-SMX. Her skin prick test with TMP-SMX was negative, but she developed anaphylaxis in a drug provocation test (DPT). An additional basophil activation test (BAT) for the TMP-SMX combination tablet was evaluated and was confirmed positive. This case underscores the need for alternative diagnostic methods like BAT, which pose a lower risk than DPT. The findings suggest that BAT could offer a safer diagnostic approach, though more studies are required to validate its use for TMP-SMX allergy diagnosis.
甲氧苄啶-磺胺甲恶唑(TMP-SMX)是一种非β-内酰胺类抗生素,常用于儿科治疗感染及作为预防用药。对TMP-SMX的超敏反应通常不是速发型的,包括过敏反应在内的速发型过敏反应很罕见。本病例报告详细介绍了一名6岁女孩,她对TMP-SMX发生了过敏反应。她的TMP-SMX皮肤点刺试验结果为阴性,但在药物激发试验(DPT)中出现了过敏反应。对TMP-SMX复方片剂进行了额外的嗜碱性粒细胞活化试验(BAT),结果被确认为阳性。本病例强调了像BAT这样风险低于DPT的替代诊断方法的必要性。研究结果表明,BAT可能提供一种更安全的诊断方法,不过还需要更多研究来验证其用于TMP-SMX过敏诊断的有效性。